234 related articles for article (PubMed ID: 35107763)
1. Childhood Hypertriglyceridemia: Is It Time for a New Approach?
Sunil B; Ashraf AP
Curr Atheroscler Rep; 2022 Apr; 24(4):265-275. PubMed ID: 35107763
[TBL] [Abstract][Full Text] [Related]
2. Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis.
Hernandez P; Passi N; Modarressi T; Kulkarni V; Soni M; Burke F; Bajaj A; Soffer D
Curr Atheroscler Rep; 2021 Sep; 23(11):72. PubMed ID: 34515873
[TBL] [Abstract][Full Text] [Related]
3. Hypertriglyceridemia: new approaches in management and treatment.
Wolska A; Yang ZH; Remaley AT
Curr Opin Lipidol; 2020 Dec; 31(6):331-339. PubMed ID: 33027225
[TBL] [Abstract][Full Text] [Related]
4. Hospital Management of Severe Hypertriglyceridemia in Children.
Valaiyapathi B; Ashraf AP
Curr Pediatr Rev; 2017; 13(4):225-231. PubMed ID: 29345595
[TBL] [Abstract][Full Text] [Related]
5. Treatment of primary hypertriglyceridemia states--General approach and the role of extracorporeal methods.
Stefanutti C; Julius U
Atheroscler Suppl; 2015 May; 18():85-94. PubMed ID: 25936310
[TBL] [Abstract][Full Text] [Related]
6. Management of Mild-to-Moderate Hypertriglyceridemia.
Pulipati VP; Brinton EA; Hatipoglu B
Endocr Pract; 2022 Nov; 28(11):1187-1195. PubMed ID: 35850450
[TBL] [Abstract][Full Text] [Related]
7. Medical management of hypertriglyceridemia in pancreatitis.
Gligorijevic N; Stefanovic-Racic M; Kershaw EE
Curr Opin Gastroenterol; 2023 Sep; 39(5):421-427. PubMed ID: 37421386
[TBL] [Abstract][Full Text] [Related]
8. Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemia.
Nurmohamed NS; Dallinga-Thie GM; Stroes ESG
Expert Rev Cardiovasc Ther; 2020 Jun; 18(6):355-361. PubMed ID: 32511037
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in treating hypertriglyceridemia in patients at high risk of cardiovascular disease with apolipoprotein C-III inhibitors.
Spagnuolo CM; Hegele RA
Expert Opin Pharmacother; 2023 Jun; 24(9):1013-1020. PubMed ID: 37114828
[TBL] [Abstract][Full Text] [Related]
10. New approaches to triglyceride reduction: Is there any hope left?
Filtz A; Parihar S; Greenberg GS; Park CM; Scotti A; Lorenzatti D; Badimon JJ; Soffer DE; Toth PP; Lavie CJ; Bittner V; Virani SS; Slipczuk L
Am J Prev Cardiol; 2024 Jun; 18():100648. PubMed ID: 38584606
[TBL] [Abstract][Full Text] [Related]
11. Severe hypertriglyceridemia: Existing and emerging therapies.
Malick WA; Do R; Rosenson RS
Pharmacol Ther; 2023 Nov; 251():108544. PubMed ID: 37848164
[TBL] [Abstract][Full Text] [Related]
12. Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia.
Mszar R; Bart S; Sakers A; Soffer D; Karalis DG
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835917
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in pharmacotherapy for hypertriglyceridemia.
Sahebkar A; Chew GT; Watts GF
Prog Lipid Res; 2014 Oct; 56():47-66. PubMed ID: 25083925
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms linking hypertriglyceridemia to acute pancreatitis.
Kiss L; Fűr G; Pisipati S; Rajalingamgari P; Ewald N; Singh V; Rakonczay Z
Acta Physiol (Oxf); 2023 Mar; 237(3):e13916. PubMed ID: 36599412
[TBL] [Abstract][Full Text] [Related]
15. Investigational drugs in development for hypertriglyceridemia: a coming-of-age story.
Rhainds D; Brodeur MR; Tardif JC
Expert Opin Investig Drugs; 2019 Dec; 28(12):1059-1079. PubMed ID: 31752565
[No Abstract] [Full Text] [Related]
16. Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007-2014.
Fan W; Philip S; Granowitz C; Toth PP; Wong ND
Diabetes Care; 2019 Dec; 42(12):2307-2314. PubMed ID: 31575639
[TBL] [Abstract][Full Text] [Related]
17. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.
Ito MK
Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750
[TBL] [Abstract][Full Text] [Related]
18. Update on the management of severe hypertriglyceridemia--focus on free fatty acid forms of omega-3.
Pirillo A; Catapano AL
Drug Des Devel Ther; 2015; 9():2129-37. PubMed ID: 25914523
[TBL] [Abstract][Full Text] [Related]
19. Issues in hypertriglyceridemic pancreatitis: an update.
Scherer J; Singh VP; Pitchumoni CS; Yadav D
J Clin Gastroenterol; 2014 Mar; 48(3):195-203. PubMed ID: 24172179
[TBL] [Abstract][Full Text] [Related]
20. Hypertriglyceridemia-Causes, Significance, and Approaches to Therapy.
Santos-Baez LS; Ginsberg HN
Front Endocrinol (Lausanne); 2020; 11():616. PubMed ID: 32982991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
